NIPPON CHEMIPHAR CO., LTD.
Patent Applications and Registrations
Patent applications and USPTO patent grants for NIPPON CHEMIPHAR CO., LTD..The latest application filed is for "method for producing phenol derivative".
Company Profile
37.92.95
Trademarks
- NIPPON CHEMIPHAR CO., LTD. - Tokyo JP
- NIPPON CHEMIPHAR CO., LTD - Tokyo N/A JP
- NIPPON CHEMIPHAR CO., LTD. - Chiyoda-ku, Tokyo JP
- Nippon Chemiphar Co., Ltd. - Chiyoda-ku Tokyo JP
- Nippon Chemiphar Co., Ltd - Chiyoda-ku Tokyo JP
- Nippon Chemiphar Co. Ltd -
- NIPPON CHEMIPHAR CO., LTD. - 2-2-3, Iwamoto-cho Chiyoda-ku, Tokyo JP
- NIPPON CHEMIPHAR CO., LTD - 2-3 IWANOTO-CHOME CHIYODA-KU JP
- Nippon Chemiphar Co., Ltd. - JP JP
- Nippon Chemiphar Company, Limited - Tokyo JP
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Method For Producing Phenol Derivative App 20220289748 - HIROSE; Masaaki | 2022-09-15 |
| P2X4 receptor antagonist Grant 11,434,207 - Ushioda , et al. September 6, 2 | 2022-09-06 |
| Reagent Cartridge App 20220276277 - TANIMOTO; Norio ; et al. | 2022-09-01 |
| Method For Producing Morphinan Derivative App 20220267327 - SAITO; Daisuke ; et al. | 2022-08-25 |
| Voltage-dependent t-type calcium channel blocker Grant 11,420,944 - Tanaka , et al. August 23, 2 | 2022-08-23 |
| Use Of T-type Calcium Channel Blocker For Treating Pruritus App 20220226299 - ZAMPONI; Gerald W. ; et al. | 2022-07-21 |
| Novel Pharmaceutical Composition App 20220202752 - Abe; Michiaki ; et al. | 2022-06-30 |
| Voltage-dependent T-type calcium channel inhibitor Grant 11,370,761 - Tanaka , et al. June 28, 2 | 2022-06-28 |
| Analysis equipment for medical use Grant D953,563 - Mataki , et al. May 31, 2 | 2022-05-31 |
| Reagent cartridge Grant D953,570 - Uemura , et al. May 31, 2 | 2022-05-31 |
| Activator of peroxisome proliferator-activated receptor Grant 11,278,528 - Hirano , et al. March 22, 2 | 2022-03-22 |
| Solid dispersion Grant 11,234,984 - Itai , et al. February 1, 2 | 2022-02-01 |
| Therapeutic Or Prophylactic Agent For Nocturnal Polyuria App 20210393562 - ARUGA; Seiji ; et al. | 2021-12-23 |
| Novel Pharmaceutical Composition App 20210386696 - ABE; Michiaki ; et al. | 2021-12-16 |
| Inhibitor Of Renal Fibrosis In Diabetic Nephropathy App 20210378997 - FUKUI; Michiaki ; et al. | 2021-12-09 |
| Agent For Improving Quality Of Sleep App 20210369654 - KAWAGUCHI; Kazuhiko ; et al. | 2021-12-02 |
| Morphinan Derivative App 20210371422 - NAGASE; Hiroshi ; et al. | 2021-12-02 |
| Biochemical Reaction Substrate And Analyzer App 20210364503 - UEMURA; Kenji ; et al. | 2021-11-25 |
| Agent For Suppressing Alcohol Sickness Or Hangover Due To Alcoholic Beverage Ingestion App 20210353575 - KAWAGUCHI; Kazuhiko ; et al. | 2021-11-18 |
| Voltage-dependent T-type Calcium Channel Inhibitor App 20210323930 - Tanaka; Hiroto ; et al. | 2021-10-21 |
| Medicine For Diabetic Peripheral Neuropathy App 20210205326 - IMAI; Toshiyasu | 2021-07-08 |
| Metabolism Improving Agent App 20210196747 - MASUZAKI; Hiroaki ; et al. | 2021-07-01 |
| Morphinan derivative Grant 10,995,092 - Nagase , et al. May 4, 2 | 2021-05-04 |
| Blood Purification By Alkalinizing Agent App 20210121426 - ABE; Michiaki ; et al. | 2021-04-29 |
| Medicament For Treatment Of Multiple Sclerosis App 20210121478 - IMAI; Toshiyasu ; et al. | 2021-04-29 |
| Chip for the analysis of biochemical reactions Grant D916,309 - Mataki , et al. April 13, 2 | 2021-04-13 |
| Morphinan Derivative App 20210040094 - NAGASE; Hiroshi ; et al. | 2021-02-11 |
| Medicament For Treating Cough App 20210000840 - IMAI; Toshiyasu ; et al. | 2021-01-07 |
| Solid Dispersion App 20200306251 - Itai; Shigeru ; et al. | 2020-10-01 |
| Activator Of Peroxisome Proliferator-activated Receptor App 20200268719 - Hirano; Masuharu ; et al. | 2020-08-27 |
| P2x4 Receptor Antagonist App 20200223806 - USHIODA; Masatoshi ; et al. | 2020-07-16 |
| Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma Grant 10,660,882 - Takeuchi , et al. | 2020-05-26 |
| Drug for preventing, treating or preventing metastasis of giant cell tumor that occurs in bone or soft parts, chondrosarcoma, or osteosarcoma, local injection for arterial embolization, and artificial bone Grant 10,653,667 - Takeuchi , et al. | 2020-05-19 |
| P2X4 receptor antagonist Grant 10,633,349 - Ushioda , et al. | 2020-04-28 |
| Morphinan Derivative App 20200079775 - NAGASE; Hiroshi ; et al. | 2020-03-12 |
| P2X4 receptor antagonist Grant 10,472,333 - Sakuma , et al. Nov | 2019-11-12 |
| USE OF MORPHINAN DERIVATIVE FOR THERAPEUTIC TREATMENT OF OPIOID delta RECEPTOR AGONIST-RELATED DISEASE App 20190328725 - NAGASE; Hiroshi ; et al. | 2019-10-31 |
| Morphinan derivative Grant 10,442,802 - Nagase , et al. Oc | 2019-10-15 |
| Drug for preventing and/or treating dementia Grant 10,413,546 - Nishino , et al. Sept | 2019-09-17 |
| Wound-healing Agent App 20190255022 - HIRAI; Toshitake ; et al. | 2019-08-22 |
| Gpr119 Agonist App 20190192510 - ENDO; Tsuyoshi ; et al. | 2019-06-27 |
| Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma Grant 10292974 - | 2019-05-21 |
| Voltage-dependent T-type Calcium Channel Blocker App 20190077767 - TANAKA; Hiroto ; et al. | 2019-03-14 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20190046539 - IMAI; Toshiyasu ; et al. | 2019-02-14 |
| URAT1 inhibitor Grant 10,173,990 - Endo , et al. J | 2019-01-08 |
| P2X4 receptor antagonist Grant 10,150,744 - Sakuma , et al. Dec | 2018-12-11 |
| P2x4 Receptor Antagonist App 20180319752 - SAKUMA; Shogo ; et al. | 2018-11-08 |
| P2x4 Receptor Antagonist App 20180201587 - USHIODA; Masatoshi ; et al. | 2018-07-19 |
| P2X4 receptor antagonist Grant 9,969,700 - Ushioda , et al. May 15, 2 | 2018-05-15 |
| Morphinan derivative Grant 9,963,460 - Nagase , et al. May 8, 2 | 2018-05-08 |
| Drug For Preventing And/or Treating Dementia App 20180117047 - NISHINO; Takeshi ; et al. | 2018-05-03 |
| Morphinan Derivative App 20180057493 - NAGASE; Hiroshi ; et al. | 2018-03-01 |
| P2X4 receptor antagonist Grant 9,873,683 - Sakuma , et al. January 23, 2 | 2018-01-23 |
| Urat1 Inhibitor App 20170290795 - Endo; Tsuyoshi ; et al. | 2017-10-12 |
| Morphinan derivative Grant 9,624,223 - Nagase , et al. April 18, 2 | 2017-04-18 |
| P2x4 Receptor Antagonist App 20170081294 - SAKUMA; Shogo ; et al. | 2017-03-23 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20170065608 - IMAI; Toshiyasu ; et al. | 2017-03-09 |
| Preventive or therapeutic agent for pain associated with herpes zoster in acute phase Grant 9,561,235 - Inoue , et al. February 7, 2 | 2017-02-07 |
| Drug For Preventing, Treating Or Preventing Metastasis Of Giant Cell Tumor That Occurs In Bone Or Soft Parts, Chondrosarcoma, Or Osteosarcoma, Local Injection For Arterial Embolization, And Artificial Bone App 20160303073 - TAKEUCHI; Akihiko ; et al. | 2016-10-20 |
| Pharmaceutical containing PPAR-delta agonist Grant 9,463,185 - Nakamura , et al. October 11, 2 | 2016-10-11 |
| P2x4 Receptor Antagonist App 20160280667 - USHIODA; Masatoshi ; et al. | 2016-09-29 |
| P2x4 Receptor Antagonist App 20160244434 - SAKUMA; Shogo ; et al. | 2016-08-25 |
| P2X4 receptor antagonist Grant 9,382,236 - Ushioda , et al. July 5, 2 | 2016-07-05 |
| Morphinan Derivative App 20160122349 - NAGASE; Hiroshi ; et al. | 2016-05-05 |
| Preventive Or Therapeutic Agent For Pain Associated With Herpes Zoster In Acute Phase App 20150328231 - INOUE; Kazuhide ; et al. | 2015-11-19 |
| P2X.sub.4 receptor antagonist Grant 8,962,613 - Sakuma , et al. February 24, 2 | 2015-02-24 |
| Prophylactic Or Therapeutic Agent For Giant Cell Tumors Occurring In Bone And Soft Tissue Or For Chondrosarcoma App 20150045396 - Takeuchi; Akihiko ; et al. | 2015-02-12 |
| Morphinan derivative Grant 8,952,030 - Nagase , et al. February 10, 2 | 2015-02-10 |
| P2x4 Receptor Antagonist App 20140357858 - Ushioda; Masatoshi ; et al. | 2014-12-04 |
| PHARMACEUTICAL CONTAINING PPAR-delta AGONIST App 20140343109 - NAKAMURA; Yoshikuni ; et al. | 2014-11-20 |
| Morphinan Derivative App 20140343015 - Nagase; Hiroshi ; et al. | 2014-11-20 |
| Pharmaceutical containing PPAR delta agonist Grant 8,802,705 - Nakamura , et al. August 12, 2 | 2014-08-12 |
| Diazepinedione derivative Grant 8,778,933 - Sakuma , et al. July 15, 2 | 2014-07-15 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20140163013 - Imai; Toshiyasu ; et al. | 2014-06-12 |
| Preventive Or Therapeutic Agent For Pain Associated With Herpes Zoster In Acute Phase App 20140148599 - Inoue; Kazuhide ; et al. | 2014-05-29 |
| P2X.sub.4 receptor antagonist Grant 8,680,110 - Ushioda , et al. March 25, 2 | 2014-03-25 |
| P 2.times.4 receptor antagonist Grant 8,673,915 - Ushioda , et al. March 18, 2 | 2014-03-18 |
| Activating agent for peroxisome proliferator activated receptor Grant 8,648,208 - Sakuma , et al. February 11, 2 | 2014-02-11 |
| Gpr119 Agonist App 20140018537 - ENDO; Tsuyoshi ; et al. | 2014-01-16 |
| Diazepinedione Derivative App 20130281441 - Sakuma; Shogo ; et al. | 2013-10-24 |
| GPR119 agonist Grant 8,536,176 - Endo , et al. September 17, 2 | 2013-09-17 |
| Activating Agent For Peroxisome Proliferator Activated Receptor Delta App 20130217734 - Sakuma; Shogo ; et al. | 2013-08-22 |
| P2x4 Receptor Antagonist App 20130184459 - Ushioda; Masatoshi ; et al. | 2013-07-18 |
| P 2 X 4 Receptor Antagonist App 20130178625 - Ushioda; Masatoshi ; et al. | 2013-07-11 |
| P2x4 Receptor Antagonist App 20130172550 - Sakuma; Shogo ; et al. | 2013-07-04 |
| Diazepinedione derivative Grant 8,470,814 - Sakuma , et al. June 25, 2 | 2013-06-25 |
| G-protein-conjugated Receptor Having Altered Ligand Affinity, And Use Thereof App 20130149715 - Muramatsu; Ikunobu | 2013-06-13 |
| Activating agent for peroxisome proliferator activated receptor .delta. Grant 8,404,726 - Sakuma , et al. March 26, 2 | 2013-03-26 |
| Agent for overcoming resistance to anti-cancer agent Grant 8,314,085 - Hirano , et al. November 20, 2 | 2012-11-20 |
| Gpr119 Agonist App 20120245344 - Endo; Tsuyoshi ; et al. | 2012-09-27 |
| Methods of using an alpha-1-adrenergic receptor having altered ligand affinity Grant 8,173,378 - Muramatsu May 8, 2 | 2012-05-08 |
| Diazepinedione Derivative App 20110319610 - Sakuma; Shogo ; et al. | 2011-12-29 |
| Agent For Overcoming Resistance To Anti-cancer Agent App 20110257201 - HIRANO; Masuharu ; et al. | 2011-10-20 |
| Gpr119 Agonist App 20110137032 - Endo; Tsuyoshi ; et al. | 2011-06-09 |
| P2x4 Receptor Antagonist App 20110092703 - Sakuma; Shogo ; et al. | 2011-04-21 |
| Therapeutic Or Prophylactic Agent For Cerebral Aneurysm App 20110092484 - Hashimoto; Nobuo ; et al. | 2011-04-21 |
| Salt Of (2s, 3s) -3- [ [ (1s) -1- Isobutoxymethyl-3-methylbutyl] Carbamyl] Oxirane-2-carboxylic Acid App 20110003993 - TENDO; Atsushi ; et al. | 2011-01-06 |
| Regulator For Signaling Toll-like Receptor, Which Comprises Cathepsin Inhibitor As Active Ingredient App 20100331545 - Takayanagi; Hiroshi ; et al. | 2010-12-30 |
| P2x4 Receptor Antagonist App 20100256123 - Sakuma; Shogo ; et al. | 2010-10-07 |
| Agent For Overcoming Resistance To Anti-cancer Agent App 20100234399 - Hirano; Masuharu ; et al. | 2010-09-16 |
| Salt of (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl] carbamoyl] oxirane-2-carboxylic acid Grant 7,795,458 - Tendo , et al. September 14, 2 | 2010-09-14 |
| Activator of peroxisome proliferator-activated receptor .delta. Grant 7,652,045 - Sakuma , et al. January 26, 2 | 2010-01-26 |
| Activator for peroxisome proliferator-activated receptor .delta. Grant 7,648,999 - Sakuma , et al. January 19, 2 | 2010-01-19 |
| Salt Of (2s, 3s)-3-[[ (1s)-1-isobutoxymethyl-3-methylbutyl] Carbamoyl] Oxirane-2-carboxylic Acid App 20090312563 - TENDO; Atsushi ; et al. | 2009-12-17 |
| Activating Agent For Peroxisome Proliferator Activated Receptor Delta App 20090298896 - Sakuma; Shogo ; et al. | 2009-12-03 |
| Substituted 1,3-thiazolo[5,4-d]pyrimidines as xanthine oxidase inhibitors Grant 7,598,254 - Yoshida , et al. October 6, 2 | 2009-10-06 |
| Salt of (2S, 3S) -3- [[(1S) -1- isobutoxymethyl-3-methylbutyl] carbamoly] oxirane-2-carboxylic acid Grant 7,585,988 - Tendo , et al. September 8, 2 | 2009-09-08 |
| Activator for Peroxisome Proliferator-Activated Receptor App 20090203908 - Sakuma; Shogo ; et al. | 2009-08-13 |
| Xanthine Oxidase Inhibitor App 20090149452 - Nishino; Takeshi ; et al. | 2009-06-11 |
| Activator of peroxisome proliferator-activated receptor .delta. Grant 7,402,597 - Sakuma , et al. July 22, 2 | 2008-07-22 |
| Xanthine Oxidase Inhibitor App 20070265283 - Yoshida; Shinichi ; et al. | 2007-11-15 |
| Activator of peroxisome proliferator-activated re-ceptor .delta. Grant 7,265,137 - Sakuma , et al. September 4, 2 | 2007-09-04 |
| Substituted thiazolopyrimidines as xanthine oxidase inhibitors Grant 7,253,154 - Yoshida , et al. August 7, 2 | 2007-08-07 |
| Salt of (2s, 3s) -3- [ [ (is) -1- isobutoxymethyl-3-methylbutyl] carbamoly] oxirane-2-carboxylic acid App 20060252826 - Tendo; Atsushi ; et al. | 2006-11-09 |
| Activator of peroxisome proliferator-activated receptor delta Grant 7,119,104 - Sakuma , et al. October 10, 2 | 2006-10-10 |
| Activator for peroxisome proliferator-activated receptor Grant 7,078,422 - Sakuma , et al. July 18, 2 | 2006-07-18 |
| Amine derivative App 20050288530 - Tendo, Atsushi ; et al. | 2005-12-29 |
| PPAR delta activators Grant 6,787,552 - Sakuma , et al. September 7, 2 | 2004-09-07 |
| Quinazoline derivatives Grant 6,706,705 - Nishioka , et al. March 16, 2 | 2004-03-16 |
| Epoxysuccinamide derivatives Grant 6,689,785 - Nomura , et al. February 10, 2 | 2004-02-10 |
| Modified low density lipoprotein receptor Grant 6,197,937 - Sawamura , et al. March 6, 2 | 2001-03-06 |
| Visceral fat lowering agent Grant 6,121,288 - Masui , et al. September 19, 2 | 2000-09-19 |
| Method for inducing death of neoplastic cells using piperazine derivatives Grant 6,054,437 - Eilon , et al. April 25, 2 | 2000-04-25 |
| Recombinant production of human and bovine receptors for modified low-density lipoprotein Grant 5,962,260 - Sawamura , et al. October 5, 1 | 1999-10-05 |
| N-aminoalkyl-substituted nitrogen-containing six membered heterocyclic compounds Grant 5,852,006 - Masaki , et al. December 22, 1 | 1998-12-22 |
| N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds Grant 5,574,030 - Masaki , et al. November 12, 1 | 1996-11-12 |
| Stabilized benzimidazole derivative and composition Grant 5,294,439 - Yamasaka , et al. March 15, 1 | 1994-03-15 |
| Glycerol derivative and anti-hypertensive agent Grant 5,183,811 - Masaki , et al. February 2, 1 | 1993-02-02 |
| Certain glyceryl phosphate-cyclic ammonium compounds useful for treating hypertension Grant 5,053,402 - Masaki , et al. October 1, 1 | 1991-10-01 |
| Process for protection of brain cells Grant 4,804,657 - Kogure , et al. February 14, 1 | 1989-02-14 |
| Plasminogen activator derivatives Grant 4,640,835 - Shimizu , et al. * Fe | 1987-02-03 |
| Guanidinocyclohexanecarboxylic acid derivatives Grant 4,465,851 - Muramatsu , et al. August 14, 1 | 1984-08-14 |
| Amidinopiperidine derivatives Grant 4,433,152 - Muramatsu , et al. February 21, 1 | 1984-02-21 |
| N-Acylcarnosine aluminum salt, its preparation, and a digestive ulcer remedy containing such salt Grant 4,342,774 - Okabe , et al. August 3, 1 | 1982-08-03 |
| N-Acylcarnosine aluminum salts Grant 4,339,378 - Masaki , et al. July 13, 1 | 1982-07-13 |
| 5-Phenethyl-2-oxazolidone derivatives and a process for producing the same Grant 4,236,012 - Fujimoto , et al. November 25, 1 | 1980-11-25 |
| Antigen membranes for use in syphilis diagnosis and syphilis diagnosis apparatus using such membranes Grant 4,081,334 - Suzuki , et al. March 28, 1 | 1978-03-28 |
| 5-Benzyl-2-oxazolidone derivatives and a process for producing the same Grant 4,062,862 - Fujimoto , et al. December 13, 1 | 1977-12-13 |
| Theophylline derivatives Grant 3,896,127 - Takahashi , et al. July 22, 1 | 1975-07-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 